Stanford University
Showing 6,151-6,200 of 37,053 Results
-
Pasqualina Colella
Affiliate, Pediatrics - Genetics
BioDr. Pasqualina Colella is a scientist with expertise in gene and cell therapy for inherited diseases. She is currently a Senior Research Scientist at Stanford University, where she leads translational research on hematopoietic stem cell transplantation (HSCT), microglia replacement, myeloid cell recruitment to the central nervous system, and genome editing. Her goal is to improve treatment outcomes for neurodegenerative lysosomal storage diseases.
Dr. Colella earned her PhD at TIGEM (Italy), where she developed gene therapies for inherited retinal disorders, including dual AAV approaches for large gene delivery targeting Usher syndrome type 1B and Stargardt disease. During her postdoctoral studies at Genethon (France), she advanced AAV-based gene therapy for Pompe disease, improving efficacy through transgene and promoter engineering. Her work has contributed to several ongoing clinical trials, including those for USH1B and Pompe disease.
Her research has led to more than 30 peer-reviewed publications (16 as first author, 7 as co-corresponding) and 6 patents. She has received awards including the Marie Skłodowska-Curie Fellowship, the Innovative Research Grant from the National MPS Society, and Stanford School of Medicine Shoshana Levy Award to Support Women in Science (Career Development Award). She was also a finalist for the ERC Starting Grant in 2019. -
Catherine Nicole Coleman
Research Director, Humanities+Design, Center for Interdisciplinary Digital Research
Affiliate, ClassicsBioNicole is Digital Research Architect for the Stanford University Libraries and Research Director for Humanities+Design, a research lab at the Center for Spatial and Textual Analysis. Nicole works at the intersection of the digital library and digital scholarship as a lead architect in the design and development of practical research services. She is currently leading an initiative within the Library to identify and enact applications of artificial intelligence —machine perception, machine learning, machine reasoning, and language recognition— to make the collections of maps, photographs, manuscripts, data sets and other assets more easily discoverable, accessible, and analyzable.
At Humanities + Design she has led the design and development of numerous tools for data visualization and analysis including Palladio, Breve, and Data Pen. The lab encourages and supports collaboration between researchers from the humanities and design to encode interpretive method in tools for data analysis. Lessons learned in that work have proven essential to improving the design of machine learning based tools for research. -
Todd Coleman
Associate Professor of Bioengineering and, by courtesy, of Electrical Engineering
BioTodd P. Coleman is a Wu Tsai Neurosciences Institute Faculty Scholar and an Associate Professor in the Department of Bioengineering, and by courtesy, Electrical Engineering at Stanford University. He received B.S. degrees in electrical engineering (summa cum laude), as well as computer engineering (summa cum laude) from the University of Michigan (Go Blue). He received M.S. and Ph.D. degrees from MIT in electrical engineering and computer science. He did postdoctoral studies at MIT and Mass General Hospital in quantitative neuroscience. He previously was a faculty member in the Departments of Electrical & Computer Engineering and Bioengineering at the University of Illinois, Urbana-Champaign, and the University of California, San Diego, respectively. Dr. Coleman’s research is very multi-disciplinary, using tools from applied probability, physiology, and bioelectronics. Examples include, for instance, optimal transport methods in high-dimensional uncertainty quantification and developing technologies and algorithms to monitor and modulate physiology of the nervous systems in the brain and visceral organs. He has served as a Principal Investigator on grants from the NSF, NIH, Department of Defense, and multiple private foundations. Dr. Coleman is an inventor on 10 granted US patents. He has been selected as a Gilbreth Lecturer for the National Academy of Engineering, a TEDMED speaker, and a Fellow of IEEE as well as the American Institute for Medical and Biological Engineering. He recently served as Chair of the National Academies Standing Committee on Biotechnology Capabilities and National Security Needs. He is currently a deputy director of the Wu Tsai Neurosciences Institute at Stanford University.
-
A. Dimitrios Colevas, MD
Professor of Medicine (Oncology) and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsMulti- modality treatment of Head and Neck Cancer
Phase 1 clinical trials -
Stella Colic
Director, Business Operations, Office of Technology Licensing (OTL)
BioStella manages OTL’s finance and business operations and leads the teams in the following areas: finance, intake and sponsor compliance, HR and IT support.
-
Roy Collins, MD, MPH
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Roy Collins, MD is a board-certified psychiatrist and Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. He serves as an Attending Sports Psychiatrist and conducts mental performance research with the Wu Tsai Human Performance Alliance, supporting athletes across collegiate, professional, and international levels. Dr. Collins is the founder of the nation’s first Sports and Performance Psychiatry Fellowship, a pioneering program that provides advanced training in athlete mental health and performance psychiatry. His work bridges clinical expertise, lived experience, elite athletic background, and a commitment to advancing science in service of mental wellness and human performance.
-
Steven Hartley Collins
Associate Professor of Mechanical Engineering and, by courtesy, of Bioengineering
BioSteve Collins is an Associate Professor of Mechanical Engineering at Stanford University, where he teaches courses on design and robotics and directs the Stanford Biomechatronics Laboratory. His primary focus is to speed and systematize the design and prescription of prostheses and exoskeletons using versatile device emulator hardware and human-in-the-loop optimization algorithms (Zhang et al. 2017, Science). Another interest is efficient autonomous devices, such as highly energy-efficient walking robots (Collins et al. 2005, Science) and exoskeletons that use no energy yet reduce the metabolic energy cost of human walking (Collins et al. 2015, Nature).
Prof. Collins received his B.S. in Mechanical Engineering in 2002 from Cornell University, where he performed undergraduate research on passive dynamic walking robots. He received his Ph.D. in Mechanical Engineering in 2008 from the University of Michigan, where he performed research on the dynamics and control of human walking. He performed postdoctoral research on humanoid robots at T. U. Delft in the Netherlands. He was a professor of Mechanical Engineering and Robotics at Carnegie Mellon University for seven years. In 2017, he joined the faculty of Mechanical Engineering at Stanford University.
Prof. Collins is a member of the Scientific Board of Dynamic Walking and the Editorial Board of Science Robotics. He has received the Young Scientist Award from the American Society of Biomechanics, the Best Medical Devices Paper from the International Conference on Robotics and Automation, and the student-voted Professor of the Year in his department. -
James Collman
George A. and Hilda M. Daubert Professor of Chemistry, Emeritus
BioProfessor Emeritus James Collman has made landmark contributions to inorganic chemistry, metal ion biochemistry, homogeneous catalysis, and transition metal organometallic chemistry. He pioneered numerous now-popular research tools to reveal key structural and functional details of metalloenzymes essential to respiration and energy, and hemoglobin and myoglobin, essential to oxygen transport in the blood.
Born 1932 in Beatrice, Nebraska, James P. Collman studied chemistry at U. Nebraska–Lincoln (B.S. 1954, M.S. 1956). His doctoral work at U. Illinois at Urbana-Champaign (Ph.D., 1958) focused on Grignard reagents. As a faculty member at U. North Carolina, he demonstrated aromatic reactivity in metal acetylacetonates, and he developed metal complexes that hydrolyze peptide bonds under physiological conditions. He came to Stanford University as Professor of Chemistry in 1967. Among many honors, Prof. Collman’s was elected to the National academy of Sciences in 1975, and named California Scientist of the Year in 1983.
At Stanford, Prof. Collman invented a new paradigm for studying biological systems using functional synthetic analogs of metal-containing enzyme systems, free from the protein coatings that can affect metalloprotein chemical properties. This strategy allowed him to elucidate the intrinsic reactivity of the metal center as well as the effects of protein-metal interactions on biological function.
One focal point of this research has involved heme-proteins such as the oxygen (O2) carrier hemoglobin (Hb), and the O2-storing protein myoglobin (Mb). Prof. Collman was the first to prepare and characterize stable, functional analogues of the Hb and Mb active sites, which contain an iron derivative of the large flat “porphyrin” ligand. In his “picket fence” porphyrin, groups installed on the periphery block side reactions, which would otherwise degrade the structure. This protected iron complex manifests the unique magnetic, spectroscopic and structural characteristics of the O2-binding Hb and Mb sites, and exhibits very similar O2-binding affinities.
The Collman Group also prepared functional mimics of the O2-binding/reducing site in a key respiration enzyme, cytochrome c oxidase, CcO, which converts O2 to H2O during biosynthesis of the energy storage molecule ATP. This enzyme must be very selective: partial O2 reduction products are toxic. Prof. Collman invented a powerful synthetic strategy to create analogs of the CcO active site and applied novel electrochemical techniques to demonstrate that these models catalyze the reduction of O2 to water without producing toxic partially-reduced species. He was able to mimic slow, rate-limiting electron delivery by attaching his CcO model to a liquid-crystalline membrane using “click chemistry.” He demonstrated that hydrogen sulfide molecules and heterocycles reversibly bind to the metal centers at CcO’s active site, connecting a synthetic enzyme model to simple molecules that reversibly inhibit respiration. These respiration inhibitors exhibit physiological properties, affecting blood clotting and controlling the effects of the hormone, nitric oxide, NO.
In addition, Prof. Collman performed fundamental studies of organometallic reactions. He also prepared and characterized homodinuclear and heterodinuclear complexes having metal-metal multiple bonds, and made the first measurements of the rotational barriers found in multiple metal-metal bonds.
Prof. Collman’s impactful textbook “Principles and Applications of Organotransition Metal Chemistry” has seen multiple editions. His book “Naturally Dangerous: Surprising Facts About Food, Health, and the Environment” explains the science behind everyday life, and received favorable reviews in Nature and The Washington Post. -
Dan Colman
Dean-Admin, Academic Council, Continuing Studies and Summer Session
BioDan Colman is the Dean of Continuing Studies & Summer Session Programs, overseeing a unit of five programs that make Stanford courses accessible to approximately 24,000 students worldwide. The unit houses the following programs:
—Stanford Continuing Studies is an open enrollment program that offers adult learners affordable courses in the liberal arts & sciences, creative writing, and business and technology. The program presents 550 on-campus and online courses each year.
—Stanford Summer Session is the university’s fourth academic quarter. Enabling students to take 8-week Stanford courses and receive Stanford credit, the program serves matriculated Stanford students as well as visiting undergraduates, graduate students, and advanced high school students.
—Stanford Online High School is an independent, diploma-granting school for grades 7–12, where dedicated instructors help academically advanced students worldwide pursue their passions in live, online seminars.
—Stanford Pre-Collegiate Studies serves middle school and high school students, allowing them to attend academically enriching programs that cover advanced subjects–ones rarely taught in local schools. Programs take place online and on campus, with residential programs offered during the summer.
—Stanford Distinguished Careers Institute (DCI) inspires accomplished individuals to thrive in the next chapter of their lives by providing opportunities to discover, connect, and contribute through engagement within Stanford’s diverse academic community.
Before his current position, Dan was the Director & Associate Dean of Continuing Studies from 2006-2019. In this role, he introduced online courses to the curriculum and helped Continuing Studies evolve from a local Bay Area program to one serving learners across the United States and the globe. Notably, Continuing Studies became Zoom’s first customer in 2012 and used the platform to enhance the interactivity and engagement of its online courses.
From 2001–2005, Dan served in leadership roles at the Alliance for Lifelong Learning, an early e-learning venture backed by Stanford, Oxford, and Yale. The consortium developed some of the first online courses offered by these universities, gearing them toward alumni and lifelong learners worldwide. He also worked at About.com, a leading information website during the dot-com era, where he developed expertise in digital media and online publishing.
Dan received a Ph.D. in History from Stanford. In his dissertation, he focused on the French Revolution and how moderate politicians attempted to use education and Enlightenment philosophy to stabilize the French Republic after the Terror. -
Ruben J Colman, MD, PhD
Assistant Professor of Pediatrics (Gastroenterology)
BioDr. Colman is a pediatric gastroenterologist and physician-scientist with an overarching goal to improve and optimize the quality of care and outcomes for children with inflammatory bowel diseases (IBD) through precision medicine approaches. His interdisciplinary team science research program focuses on making precision medicine clinically actionable through innovative solutions merging clinical pharmacology knowledge with ‘-omics’ discoveries using microbiome and metabolomics signatures. Part of this work includes translating these findings into improved clinical treat-to-target endpoints with immediate noninvasive point-of-care measures such as intestinal ultrasound.
The foundation of his current work originates from his PhD titled ‘Precision Dosing and Personalized Medicine in pediatric IBD’. During his training, Dr. Colman was also an American Gastroenterological Association (AGA) editorial fellow for Gastroenterology and he is actively involved in the committees of several professional societies including the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), the Crohn’s and Colitis Foundation and the International Bowel UltraSound (IBUS) Group. Dr. Colman is supported by a Career Development K23 Award from the NIH, which focuses on evaluating personalized treatment strategies for children with Crohn's disease, specifically examining microbial and transmural intestinal ultrasound findings. He is also funded by awards of the NASPGHAN Foundation and the Stanford Pediatrics Physician-Scientist Bridge to K Program.
